BioPharma Credit raises $153.9m in ABB
BioPharma Credit, the closed end investment fund that provides debt capital for the life sciences industry, raised $153.9m in an accelerated bookbuild yesterday to fund investments.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: